← Browse by Condition
Medical Condition

stage iii pancreatic neuroendocrine tumor ajcc v8

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05687123 Phase 1
Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Enrollment
24 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT05040360 Phase 2
Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Enrollment
141 pts
Location
United States, Mexic...
Sponsor
SWOG Cancer Research Network
View Trial →